RT-PCR VERSUS IMMUNOHISTOCHEMISTRY FOR CORRELATION AND QUANTIFICATION OF ERCC1, BRCA1, TUBB3 & RRM1 IN NSCLC

被引：0
|
作者：
Vilmar, Adam [1 ]
Garcia-Focillas, Jesus [2 ]
Huarriz, Marisol [2 ]
Santoni-Rugiu, Eric [3 ]
Sorensen, Jens B. [1 ]
机构：
[1] Natl Univ Hosp, Finsen Ctr, Copenhagen, Denmark
[2] Univ Navarra, Lab Pharmacogenom, Div Oncol, Ctr Appl Med Res Cima, E-31080 Pamplona, Spain
[3] Natl Univ Hosp, Ctr Diagnost, Copenhagen, Denmark
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
NSCLC; predictive markers; methodology; qRT-PCR; immunohistochemical evaluation;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1518 / S1519
页数：2
相关论文
共 50 条
  • [41] ERCC1, RRM1 and BRCA1 mRNA expression levels and clinical outcome of advanced non-small cell lung cancer
    Chunxia Su
    Songwen Zhou
    Ling Zhang
    Shengxiang Ren
    Jianfang Xu
    Jie Zhang
    Meijun Lv
    Jie Zhang
    Caicun Zhou
    Medical Oncology, 2011, 28 : 1411 - 1417
  • [42] In Situ Protein Expression of RRM1, ERCC1, and BRCA1 in Metastatic Breast Cancer Patients Treated with Gemcitabine-Based Chemotherapy
    Metro, G.
    Zheng, Z.
    Fabi, A.
    Schell, M.
    Antoniani, B.
    Mottolese, M.
    Monteiro, A. N.
    Vici, P.
    Rivera, S. Lara
    Boulware, D.
    Cognetti, F.
    Bepler, G.
    CANCER INVESTIGATION, 2010, 28 (02) : 172 - 180
  • [43] In situ protein expression of RRM1, ERCC1, and BRCA1 in metastatic breast cancer patients treated with gemcitabine-including chemotherapy
    Metro, G.
    Zheng, Z.
    Fabi, A.
    Mottolese, M.
    Monteiro, A. N.
    Vici, P.
    Boulware, D.
    Rivera, S. Lara
    Cognetti, F.
    Bepler, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [44] ERCC1, RRM1 and BRCA1 mRNA expression levels and clinical outcome of advanced non-small cell lung cancer
    Su, Chunxia
    Zhou, Songwen
    Zhang, Ling
    Ren, Shengxiang
    Xu, Jianfang
    Zhang, Jie
    Lv, Meijun
    Zhang, Jie
    Zhou, Caicun
    MEDICAL ONCOLOGY, 2011, 28 (04) : 1411 - 1417
  • [45] Prognostic significance of ERCC1, RRM1, TOP1, TOP2A, TYMS, TUBB3, GSTP1 and BRCA1 mRNA expressions in patients with non-small-cell lung cancer receiving a platinum-based chemotherapy
    Tsyganov, Matvey M.
    Rodionov, Evgeny O.
    Pevzner, Alina M.
    Ibragimova, Marina K.
    Miller, Sergey, V
    Cheremisina, Olga, V
    Frolova, Irina G.
    Tuzikov, Sergey A.
    Litviakov, Nikolai, V
    JOURNAL OF BUON, 2020, 25 (04): : 1728 - 1736
  • [46] ERCC1、RRM1和BRCA1在非小细胞肺癌中的表达及预后意义
    陈芹
    周彩存
    张颉
    肿瘤, 2007, (09) : 719 - 722
  • [47] ERCC1, RRM1, and BRCA1 mRNA expression levels and clinical outcome of advanced non-small cell lung cancer
    Su, C.
    Zhou, S.
    Zhang, L.
    Ren, S.
    Zhou, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [48] Prognostic significance of BRCA1, ERCC1, RRM1, and RRM2 in patients with advanced non-small cell lung cancer receiving chemotherapy
    Zhao, Hui
    Zhang, Huawei
    Du, Yonghai
    Gu, Xiaomeng
    TUMOR BIOLOGY, 2014, 35 (12) : 12679 - 12688
  • [49] Predictive effects of RRM1, ERCC1, XRCC3, BRCA1 and EGFR genotyping or expression for clinical outcome of advanced NSCLC patients treated with cisplatin-based chemotherapy or gefitinib
    Zhou, Caicun
    BIOMEDICINE & PHARMACOTHERAPY, 2009, 63 (05) : 321 - 322
  • [50] Individualized chemotherapy in the advanced NSCLC patients based on the mRNA level of BRCA1 and RRM1
    Ren, S.
    Zhou, S.
    Zhang, L.
    Chen, X.
    Zhou, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345